Drug Profile
Research programme: cancer vaccines - Astellas Pharma/Sanofi
Latest Information Update: 08 Apr 2022
Price :
$50
*
At a glance
- Originator Agensys; sanofi pasteur
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer; Prostate cancer
Most Recent Events
- 12 Oct 2005 Preclinical trials in Colorectal cancer in Canada (unspecified route)
- 12 Oct 2005 Preclinical trials in Colorectal cancer in USA (unspecified route)
- 12 Oct 2005 Preclinical trials in Prostate cancer in Canada (unspecified route)